burger

A pharmaceutical company
specialising in biological
medicinal products

15 medicines

prescribed to

hospital

3 fields of therapy
  • Immunology
  • Haemostasis
  • Intensive Care
4

BIOPRODUCTION SITES in the world

2/3

of LFB’s biomedicinal products are intended for the treatment of patients with rare diseases

Group executive committee

Committee’s composition
€ 459 M IN TURNOVER

IN 2021

1 of the leaders in France

IN THE FIELD OF PLASMA-DERIVED MEDICINAL PRODUCTS

All news

1:50

"The Powers of Blood" series: EPISODE 1 “WHAT IS BLOOD?”

4:17

November 2022: new LFB Arras plant

5:01

The fractionation of the LFB plasma-derived medicinal products : 1 plant on 2 sites

2:44

2022 LFB corporate video

All videos

Jacques Brom gives you all his best wishes for 2023!

The Powers of Blood: discover the 1st episode of the series

4th vidéo episod : the new LFB Arras plant, November 2022

LFB GOVERNANCE CHANGE: Jacques Brom is appointed CEO of LFB

LFB announces the approval of CEVENFACTA® in the European Union

Discover the new LFB CSR Charter

LFB works for « the France of tomorrow » and unveils a new industrial project in Alès

EMA acceptance for filing of the MARKETING AUTHORISATION application FOR EPTACOG BETA, THE LFB RECOMBINANT FACTOR VIIA , AND PUBLICATION OF THE EXPLORATORY IN VITRO STUDY RESULTS on eptacog beta in combination with emicizumab

1:50

"The Powers of Blood" series: EPISODE 1 “WHAT IS BLOOD?”

there is 3 weeks

4:17

November 2022: new LFB Arras plant

there is 2 months

5:01

The fractionation of the LFB plasma-derived medicinal products : 1 plant on 2 sites

there is 4 months

2:44

2022 LFB corporate video

there is 8 months